Denali Therapeutics Inc (DNLI)
16.80
+0.64
(+3.99%)
USD |
NASDAQ |
May 02, 16:00
16.80
0.00 (0.00%)
After-Hours: 20:00
Denali Therapeutics Cash and Short Term Investments (Quarterly): 1.035B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.035B |
| September 30, 2023 | 1.109B |
| June 30, 2023 | 1.191B |
| March 31, 2023 | 1.288B |
| December 31, 2022 | 1.336B |
| September 30, 2022 | 1.106B |
| June 30, 2022 | 1.069B |
| March 31, 2022 | 957.52M |
| December 31, 2021 | 865.41M |
| September 30, 2021 | 1.039B |
| June 30, 2021 | 1.309B |
| March 31, 2021 | 1.413B |
| December 31, 2020 | 1.470B |
| September 30, 2020 | 961.20M |
| Date | Value |
|---|---|
| June 30, 2020 | 549.58M |
| March 31, 2020 | 587.25M |
| December 31, 2019 | 415.36M |
| September 30, 2019 | 479.39M |
| June 30, 2019 | 478.60M |
| March 31, 2019 | 485.48M |
| December 31, 2018 | 464.30M |
| September 30, 2018 | 374.96M |
| June 30, 2018 | 372.59M |
| March 31, 2018 | 373.40M |
| December 31, 2017 | 406.23M |
| September 30, 2017 | 185.80M |
| December 31, 2016 | 178.33M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
415.36M
Minimum
Dec 2019
1.470B
Maximum
Dec 2020
982.07M
Average
1.039B
Median
Sep 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Halozyme Therapeutics Inc | 336.00M |
| AIM ImmunoTech Inc | 13.07M |
| Perspective Therapeutics Inc | 9.238M |
| Protalix BioTherapeutics Inc | 44.56M |
| Armata Pharmaceuticals Inc | 13.52M |